FDA Inspection 1248873 — IVI RMA of New Jersey
The FDA completed an inspection of IVI RMA of New Jersey on August 26, 2024 in Marlton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 26, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Marlton, NJ (United States)